Selvita S.A. (GPW: SLV) Stock Analysis & Fundamentals | ScreenerHero

Create free account

SLVSelvita S.A.

GPW · PL · Healthcare · Diagnostics & Research · selvita.com

31.80PLN+0.63%Mkt Cap: 147.80M $P/E: —1d ago

Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design,…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Cheaper

1M Perf

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap147.80M $

Enterprise Value185.32M $

Revenue (TTM)91.16M $

Gross Profit74.30M $

Net Income (TTM)205.90K $

Revenue/Share4.966 USD

Last Price31.80 PLN

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees691

CountryPL

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)19.81

PEG—

EV/EBITDA11.12

EV/Revenue2.03

P/S1.62

P/B1.84

EPS (TTM)-0.21

EPS (Forward)—

52W Range

28.1017% of range49.40

52W High49.40 PLN

52W Low28.10 PLN

Profitability

Gross Margin80.55%

Oper. Margin-2.23%

EBITDA Margin18.28%

Profit Margin0.22%

ROE0.25%

ROA0.14%

Growth

Revenue Growth-12.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF18.55M $

CapEx (TTM)1.81M $

FCF Margin16.60%

FCF Yield10.24%

Net Debt37.49M $

Net Debt/EBITDA2.25

Balance Sheet

Debt/Equity0.53

Current Ratio1.00

Quick Ratio0.87

Book Value/Sh17.27 PLN

Cash/Share1.084 PLN

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 PLN

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)47.32 PLN

Upside (mean)+48.8%

Target Range31.00 PLN – 65.30 PLN

PLN31.00+48.8% to meanPLN65.30

# Analysts6

Ownership

Shares Out.18.35M

Float9.71M

Insiders21.18%

Institutions23.38%

Technical

SMA 5031.88 (-0.3%)

SMA 20038.14 (-16.6%)

Beta0.04

S&P 52W Chg20.05%

Avg Vol (30d)28.91K

Avg Vol (10d)8.32K

Technical Indicators

RSI (14)55.2

MACD-0.1531

MACD Signal-0.3668

MACD Hist.+0.2137

BB Upper32.05 PLN

BB Middle30.63 PLN

BB Lower29.20 PLN

BB Width9.28%

ATR (14)1.117 PLN

Vol Ratio (20d)0.78x